Our results may indicate that FABP4, GISN2, and CBX7 could be considered predictive biomarkers of the occurrence of lymph node metastases in the cancer of the cervix preoperatively, which could be beneficial in the accurate preoperative design therapy. The gene discussed is FABP4; the disease is metastatic malignant neoplasm in the lymph nodes.